Can smokeless tobacco rid us of tobacco smoke?

American Journal of Medicine

Volumn 104, Issue 5, 1998, Pages 501-503

  Fagerström, Karl Olov ^a,c   Ramström, Lars ^b  

^a HELSINGBORG HOSPITAL   (Sweden)

^b Institute for Tobacco Studies   (Sweden)

^c Fagerstrom Consulting   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINE; TOBACCO SMOKE;

CIGARETTE SMOKING; EDITORIAL; PATIENT COMPLIANCE; PREVALENCE; PRIORITY JOURNAL; SMOKELESS TOBACCO; SMOKING HABIT; TREATMENT PLANNING;

HUMANS; PATIENT ACCEPTANCE OF HEALTH CARE; PLANTS, TOXIC; RESEARCH DESIGN; SMOKING; SMOKING CESSATION; TOBACCO, SMOKELESS;

EID: 0032076699     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(98)00083-7     Document Type: Editorial

References (20)

1. 1. Tilashalaski K, Rodu B, Cole P. A pilot study of smokeless tobacco in smoking cessation. Am J Med. 1998;104:456-458.
2. 2. Bolinder G, Himmelman L. Färre röker men fier snusar (in Swedish). Läkartidningen. 1996;93:4437-444.
3. 3. Fagerström KO, Ramström LM, Svensson TH. Health in tobacco control. Lancet. 1992;339:934.
4. 4. Benowitz NL, Porchet H, Sheiner L, Jacob P III. Nicotine absorption and cardiovascular effects with smokeless tobacco use: comparison with cigarettes and nicotine gum. Clin Pharmacol Therapeut. 1988;44:23-28.
5. 5. Balfour DJK, Fagerström KO. Pharmacology of nicotine and its therapeutic use in smoking cessation and neurodegenerative disorders. Pharmacol Therapeut. 1996;72:51-81.
6. 6. Fagerström KO, Schneider NG. Measuring nicotine dependence: a review of the Fagerström Tolerance Questionnaire. J Behav Med. 1989;12:159-182.
7. 7. Lewin F, Norell SE, Johansson H, et al. Smoking tobacco, oral snuff and alcohol in the etiology of squamous cell carcinoma of the head and neck. A population based case-referent study in Sweden. Cancer. 1998;82:1367-1375.
8. 8. Schildt EB, Eriksson M, Hardell L, Magnusson A. Oral snuff, other tobacco and alcohol inrelation to oral cancer - a case control study. Intern J. Cancer. In press.
9. 9. International Agency for Research on Cancer (IARC). GLOBOCan database on cancer epidemiology data. Lyon, 1997.
10. 10. Eliasson M, Asplund K, Evrin P-E, Lundblad D. Relationship of cigarette smoking and snuff dipping to plasma fibrinogen, fibrinolytic variables and serum insulin. The Northern Sweden Monica study. Atherosclerosis. 1995;113:41-53.
11. 11. Bolinder G, Noren A, de Faire U, Wahren J. Smokeless tobacco use and atherosclerosis: an ultrasonographic investigation of carotid intima media thickness in healthy middle-aged men. Atherosclerosis. 1997;132:95-103.
12. 12. Huhtasaari F, Asplund K, Lundberg V, et al. Tobacco and myocardial infarction: is snuff less dangerous than cigarettes? BMJ. 1992; 305:1252-1256.
13. 13 Bolinder G, Alfredsson L, Englund A, de Faire U. Smokeless tobacco use and increased cardiovascular mortality among Swedish construction workers. Am J Public Health. 1994;84:399-404.
14. 14. Ahlbom A, Olsson UA, Pershagen G. Health risks associated with moist snuff. Stockholm, Sweden: National Board of Health and Welfare; 1997.
15. 15. Peto R, Lopez AD, Boreham J, et al. Mortality from smoking in developed countries 1950-2000. Oxford, UK: Oxford University Press; 1994.
16. 16. Huffman D, Djordjevic MV, Fan J, et al. Five leading US commercial brands of moist snuff in 1994. Assessment of carsinogenic N-nitrosamines. J Nat Instit. 1995;87:1862-1869.
17. 17. Ramström LM. Smokeless tobacco - a potential gateway to smoking? In: Durston B, JamrozikK, eds. Tobacco and Health 1990. Proceedings of the Seventh World Conference on Tobacco and Health. Health Department of Western Australia, Perth; 1990:451-452.
18. 18. Andersson B, Hibell B. Skolelevers drogvanor 1995. (Adolescent drug use 1995). Report from CAN. Stockholm, Sweden: Swedish Council for Information on Alcohol and Other Drugs; 1995.
19. 19. Ramström L, Uranga R, Hendrie A (Eds). Social and economic aspects of reduction of tobacco smoking by use of alternative nicotine delivery systems (ANDS). Report of a Roundtable organized by the UN Focal Point on Tobacco on Health in collaboration with the International Council on Alcohol and Addictions (ICAA) and the European Medical Association Smoking on Health (EMASH). Adis International, Chester, 1998.
20. 20. Kunze U, Schoberberger R, Fagerström KO, et al. High nicotine dependence among lung cancer patients. Eur Respir J. 1996; 9(suppl):23.